Syros Pharmaceuticals, Inc. (SYRS)
NASDAQ: SYRS · Real-Time Price · USD
0.208
+0.005 (2.61%)
Dec 26, 2024, 11:48 AM EST - Market open
Syros Pharmaceuticals Employees
Syros Pharmaceuticals had 68 employees as of December 31, 2023. The number of employees decreased by 49 or -41.88% compared to the previous year.
Employees
68
Change (1Y)
-49
Growth (1Y)
-41.88%
Revenue / Employee
$5,676
Profits / Employee
-$1,438,456
Market Cap
5.59M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Evaxion Biotech | 49 |
| Predictive Oncology | 35 |
| Tenon Medical | 21 |
| Organovo Holdings | 20 |
| Moleculin Biotech | 18 |
| Coeptis Therapeutics Holdings | 7 |
| Portage Biotech | 7 |
| 180 Life Sciences | 4 |
SYRS News
- 6 weeks ago - Syros Pharmaceuticals Stock Sinks As Pivotal Blood Cancer Trial Flunks, Triggers Loan Default - Benzinga
- 6 weeks ago - Syros Announces Topline Data from SELECT-MDS-1 Phase 3 Trial of Tamibarotene in Higher-Risk Myelodysplastic Syndrome with RARA Gene Overexpression - Business Wire
- 7 weeks ago - The Schall Law Firm Invites Investors To Join An Inquiry Into Syros Pharmaceuticals, Inc. For Securities Related Infractions - Accesswire
- 7 weeks ago - Syros Pharmaceuticals Inc Is Being Investigated For Securities Fraud And Shareholders With Losses Are Encouraged To Contact The Schall Law Firm - Accesswire
- 7 weeks ago - The Schall Law Firm Urges Investors To Join An Inquiry Into Syros Pharmaceuticals, Inc. For Securities Law Violations - Accesswire
- 7 weeks ago - Syros Pharmaceuticals, Inc (SYRS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Syros Pharmaceuticals Inc Is Being Investigated For Securities Fraud And Affected Shareholders Are Encouraged To Contact The Schall Law Firm - Accesswire
- 2 months ago - Syros Reports Third Quarter 2024 Financial Results and Provides a Business Update - Business Wire